Latest News

Antidepressant plus addiction medication are elements of new weight-loss drug

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight-loss in independent research trials and the partnering of the two in one capsule is believed to create a synergistic effect.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Family criticizing your weight? You might add more pounds

  • Early exposure to antidepressants affects adult anxiety, serotonin transmission

  • Cocaine, amphetamine users more likely to take their own lives

  • New technology advances eye tracking as biomarker for brain function, recovery from brain injury

  • Tracking the eyes: The keys to consumers' plant preferences

  • Naming people, objects in baby's first year may offer learning benefits years later

  • Meth users face substantially higher risk for getting Parkinson's disease

  • First real-time mri-guided brain surgery for Parkinson's in southern California

  • How, where the brain converts external inputs into behavioral responses

  • Teen contraband smokers more likely to use illicit drugs: Study

  •